| Literature DB >> 27219867 |
Terry D Crawford1, Vickie Tsui1, E Megan Flynn1, Shumei Wang1, Alexander M Taylor2, Alexandre Côté2, James E Audia2, Maureen H Beresini1, Daniel J Burdick1, Richard Cummings2, Les A Dakin2, Martin Duplessis2, Andrew C Good2, Michael C Hewitt2, Hon-Ren Huang2, Hariharan Jayaram2, James R Kiefer1, Ying Jiang3, Jeremy Murray1, Christopher G Nasveschuk2, Eneida Pardo2, Florence Poy2, F Anthony Romero1, Yong Tang2, Jian Wang3, Zhaowu Xu3, Laura E Zawadzke2, Xiaoyu Zhu3, Brian K Albrecht2, Steven R Magnuson1, Steve Bellon2, Andrea G Cochran1.
Abstract
The biological role played by non-BET bromodomains remains poorly understood, and it is therefore imperative to identify potent and highly selective inhibitors to effectively explore the biology of individual bromodomain proteins. A ligand-efficient nonselective bromodomain inhibitor was identified from a 6-methyl pyrrolopyridone fragment. Small hydrophobic substituents replacing the N-methyl group were designed directing toward the conserved bromodomain water pocket, and two distinct binding conformations were then observed. The substituents either directly displaced and rearranged the conserved solvent network, as in BRD4(1) and TAF1(2), or induced a narrow hydrophobic channel adjacent to the lipophilic shelf, as in BRD9 and CECR2. The preference of distinct substituents for individual bromodomains provided selectivity handles useful for future lead optimization efforts for selective BRD9, CECR2, and TAF1(2) inhibitors.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27219867 DOI: 10.1021/acs.jmedchem.6b00264
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446